American Century Companies Inc. Cuts Holdings in Pediatrix Medical Group, Inc. $MD

Key Points

• American Century Companies Inc. reduced its holdings in Pediatrix Medical Group, Inc. by 13.7%, selling 237,485 shares, and now owns about 1.75% of the company valued at $21.76 million.
• Several institutional investors, including Principal Financial Group and GAMMA Investing LLC, have recently increased their stakes in Pediatrix Medical Group, highlighting a growing interest in the company among hedge funds and institutional investors.
• Pediatrix Medical Group reported a quarterly earnings per share (EPS) of $0.53, exceeding estimates and showing a year-over-year revenue decline of 7.1% despite achieving better-than-expected results.

American Century Companies Inc. lessened its holdings in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 13.7% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,501,838 shares of the company's stock after selling 237,485 shares during the period. American Century Companies Inc. owned 1.75% of Pediatrix Medical Group worth $21,762,000 as of its most recent filing with the SEC.

Other hedge funds also recently modified their holdings of the company. California State Teachers Retirement System lifted its holdings in Pediatrix Medical Group by 0.9% in the fourth quarter. California State Teachers Retirement System now owns 80,327 shares of the company's stock valued at $1,054,000 after buying an additional 752 shares during the period. SummerHaven Investment Management LLC lifted its holdings in Pediatrix Medical Group by 0.9% in the first quarter. SummerHaven Investment Management LLC now owns 112,327 shares of the company's stock valued at $1,628,000 after buying an additional 1,028 shares during the period. Natixis Advisors LLC lifted its holdings in Pediatrix Medical Group by 8.1% in the first quarter. Natixis Advisors LLC now owns 19,156 shares of the company's stock valued at $278,000 after buying an additional 1,435 shares during the period. GAMMA Investing LLC lifted its holdings in Pediatrix Medical Group by 219.5% in the first quarter. GAMMA Investing LLC now owns 2,569 shares of the company's stock valued at $37,000 after buying an additional 1,765 shares during the period. Finally, New York State Teachers Retirement System lifted its holdings in Pediatrix Medical Group by 1.9% in the first quarter. New York State Teachers Retirement System now owns 133,313 shares of the company's stock valued at $1,932,000 after buying an additional 2,527 shares during the period. Institutional investors and hedge funds own 97.71% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on MD shares. UBS Group boosted their target price on shares of Pediatrix Medical Group from $16.00 to $16.50 and gave the company a "neutral" rating in a report on Thursday, August 14th. Zacks Research upgraded shares of Pediatrix Medical Group to a "strong-buy" rating in a report on Monday, August 11th. Finally, Macquarie boosted their target price on shares of Pediatrix Medical Group from $19.00 to $20.00 and gave the company an "outperform" rating in a report on Thursday, May 8th. One research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and four have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, Pediatrix Medical Group presently has an average rating of "Moderate Buy" and an average target price of $16.75.

Pediatrix Medical Group Stock Up 0.5%

Shares of NYSE:MD traded up $0.08 during midday trading on Friday, hitting $17.18. 710,110 shares of the company's stock were exchanged, compared to its average volume of 949,238. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.80 and a quick ratio of 1.80. The stock has a 50 day moving average price of $14.13 and a 200-day moving average price of $14.04. The company has a market cap of $1.50 billion, a PE ratio of 13.32 and a beta of 1.21. Pediatrix Medical Group, Inc. has a 12 month low of $10.06 and a 12 month high of $17.67.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported $0.53 EPS for the quarter, topping the consensus estimate of $0.42 by $0.11. The company had revenue of $468.84 million during the quarter, compared to the consensus estimate of $464.37 million. Pediatrix Medical Group had a net margin of 5.66% and a return on equity of 18.94%. The firm's revenue for the quarter was down 7.1% on a year-over-year basis. During the same period in the previous year, the firm posted $0.34 earnings per share. On average, sell-side analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.